MarketPeel
Pricing
…
DT

Daniel Tardiff

CAMP
CHIEF SCIENTIFIC OFFICER · CAMP4 THERAPEUTICS CORP · CIK 0002089301
FILING MIX · LIFETIME67%/33%
BUYS
2
SELLS
1
TOTAL VALUE
$8.3K
COMPANIES
1
ACTIVE SINCE
Dec 2025
HOLDINGS NOW
0
AVG SELL PX
$4.76
TRADE KIND
SHOWING 3 / 3
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Daniel Tardiff. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
CAMP · 0 shares · as of Aug 19, 2026
042,50085,000127,500170,0002026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2025
2026
2026
2026
FLOW · 2 buys / 1 sellsCOVERAGE · 4 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CAMP
CAMP4 THERAPEUTICS CORP
SALE
Chief Scientific Officer
1,738$4.76$8.3K0Aug 19, 2026Aug 19, 2026 ↗View →
CAMP
CAMP4 THERAPEUTICS CORP
PURCHASEGRANT
Stock grant
170,000——170,000Apr 1, 2026Apr 3, 2026 ↗View →
CAMP
CAMP4 THERAPEUTICS CORP
PURCHASEGRANT
Stock grant
145,500——145,500Dec 11, 2025Dec 22, 2025 ↗View →
Other insiders · CAMP
Loading peer insiders…
About this filer
CIK 0002089301
ROLE
Chief Scientific Officer
PRIMARY
CAMP
COMPANIES
1
ACTIVE SINCE
Dec 2025
MARKETPEEL · /INSIDER/0002089301DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback